Overview
Rivoceranib is under investigation in clinical trial NCT02726854 (Apatinib as Second-line Treatment of Advanced Pancreatic Cancer).
Background
Rivoceranib is under investigation in clinical trial NCT02726854 (Apatinib as Second-line Treatment of Advanced Pancreatic Cancer).
Indication
本品单药适用于既往至少接受过2种系统化疗后进展或复发的晚期胃腺癌或胃-食管结合部腺癌患者。患者接受治疗时应一般状况良好。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/06/22 | Phase 2 | Not yet recruiting | |||
2025/03/25 | Not Applicable | Recruiting | Nanjing Tianyinshan Hospital | ||
2025/03/18 | Phase 2 | Not yet recruiting | |||
2025/02/17 | Phase 2 | Recruiting | |||
2025/01/22 | Phase 2 | Not yet recruiting | |||
2025/01/06 | Phase 2 | Not yet recruiting | Zhejiang University | ||
2024/12/27 | Phase 2 | Recruiting | |||
2024/11/19 | Phase 2 | Not yet recruiting | |||
2024/11/18 | Phase 2 | Not yet recruiting | |||
2024/08/09 | Phase 2 | Not yet recruiting | Zhujiang Hospital |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Apatinib Mesylate Tablets | 国药准字H20140103 | 化学药品 | 片剂 | 9/30/2019 | |
| Apatinib Mesylate Tablets | 国药准字H20140105 | 化学药品 | 片剂 | 9/30/2019 | |
| Apatinib Mesylate Tablets | 国药准字H20140104 | 化学药品 | 片剂 | 9/30/2019 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||